Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05689710

The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis

Conditions: Metabolic Syndrome, Cardiac Fibrosis

Sex: All

Phase: NA

Enrollment: 30

Sponsor: Lo.Li.Pharma s.r.l

Location: Italy

Summary

The study aims to evaluate the effects of an oral supplementation based on inositols and alpha-lactalbumin on principals metabolic parameters in patients with metabolic syndrome at risk of cardiac fibrosis

Eligibility Criteria

At least 3 of the following inclusion criteria:triglycerides levels ≥ 150 mg/dLHDL ≤ 40 mg/dLFasting glycemia > 100 mg/dL <126 mg/dlSystolic Pressure ≥ 130 mmHg or Diastolic pressure ≥ 85 mmHgHip circumference > 102 cm in men or 88 cm in women

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05689710). StuddyBuddy aggregates publicly available trial information.